CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATION CODE AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported)
Jul 30, 2024
2. SEC Identification Number
166411
3. BIR Tax Identification No.
000187926000
4. Exact name of issuer as specified in its charter
iPeople, inc.
5. Province, country or other jurisdiction of incorporation
Makati City
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
8th Floor, Mapua University Makati Campus, 1191 Pablo Ocampo Sr. Extension, Brgy. Sta Cruz, Makati CityPostal Code1205
8. Issuer's telephone number, including area code
(632) 8253-3637
9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common, P1.00 par value
1,044,263,197
11. Indicate the item numbers reported herein
1 and 2
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
iPeople, inc.IPO
PSE Disclosure Form 4-25 - Results of Organizational Meeting References: SRC Rule 17 (SEC Form 17-C) and Section 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
Results of Organizational Meeting
Background/Description of the Disclosure
Results of Organizational Meeting of the Board of Directors held on July 30, 2024
List of elected officers for the ensuing year with their corresponding shareholdings in the Issuer
Name of Person
Position/Designation
Shareholdings in the Listed Company
Nature of Indirect Ownership
Direct
Indirect
Dr. Reynaldo B. Vea
Chairman and Chief Executive Officer (CEO)
5
0
-
Mr. Alfredo Antonio I. Ayala
President and Chief Operating Officer (COO)
5
0
-
Ms. Gema O. Cheng
EVP - Chief Finance Officer (CFO)
0
0
-
Ms. Shirley Q. Earnhart
Treasurer
0
0
-
Mr. Victor V. Rafael
VP - Finance and Investor Relations
0
0
-
Mr. Jonathan M. Lopez
Controller
0
0
-
Mr. Narciso A. Laput
VP - Information Technology
0
0
-
Atty. Denise Jordan P. Arenillo
Legal and Compliance Officer
0
0
-
Mr. Alexander Anthony G. Galang
Chief Audit Executive
0
0
-
Ms. Pamela Q. Wu
Chief Human Resource Officer
0
0
-
Dr. Ruth C. Francisco
Chief Risk Officer
0
0
-
Atty. Samuel V. Torres
Corporate Secretary
0
0
-
Atty. Ma. Elvira Bernadette C. Garcia-Gonzalez
Asst. Corporate Secretary
0
0
-
List of Committees and Membership
Name of Committees
Members
Position/Designation in Committee
Executive Committee
Mr. Renato C. Valencia
Chairman
Executive Committee
Mr. Medel T. Nera
Member
Executive Committee
Mr. Gerardo C. Ablaza, Jr.
Member
Senior Management Committee
Mr. Lorenzo V. Tan
Chairman
Senior Management Committee
Dr. Reynaldo B. Vea
Member
Senior Management Committee
Mr. Alfredi Antonio I. Ayala
Member
Remuneration Committee
Mr. Renato C. Valencia
Chairman
Remuneration Committee
Mr. Gerardo C. Ablaza, Jr.
Member
Remuneration Committee
Ms. Herminia S. Jacinto
Member
Audit Committee
Ms. Herminia S. Jacinto
Chairman
Audit Committee
Mr. Medel T. Nera
Member
Audit Committee
Mr. William H. Ottiger
Member
Board Risk Oversight Committee
Mr. Gerardo C. Ablaza, Jr.
Chairman
Board Risk Oversight Committee
Mr. Renato C. Valencia
Member
Board Risk Oversight Committee
Ms. Herminia S. Jacinto
Member
Corporate Governance Nomination and Related Party Transaction Committee
Mr. Renato C. Valencia
Chairman
Corporate Governance Nomination and Related Party Transaction Committee
Mr. William H. Ottiger
Member
Corporate Governance Nomination and Related Party Transaction Committee
Ms. Herminia S. Jacinto
Member
Lead Independent Director
Mr. Renato C. Valencia
-
List of other material resolutions, transactions and corporate actions approved by the Board of Directors